For improved and more effective drug
development, in-vivo models ensure smooth transition from early
phase in-vitro drug target identification to later stages of compound
efficacy and potency validation in-vivo. In this respect, we have organoids
derived xenografts and direct xenotransplants of cancer tissues for more physiological
relevant in-vivo studies on therapeutic effects.
Liver cancer ODX
ODX growth curves
6-week post implantation